ID

16673

Description

Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3; ODM derived from: https://clinicaltrials.gov/show/NCT00565396

Link

https://clinicaltrials.gov/show/NCT00565396

Keywords

Versions (1)
  1. 7/31/16 7/31/16 -
Uploaded on

July 31, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Chronic Kidney Insufficiency NCT00565396

English

Eligibility Chronic Kidney Insufficiency NCT00565396

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged 18-75 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
roll out secondary renal diseases
Description

Kidney Disease Secondary

Data type

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0175668
do not use steroids and immunosuppresive drugs
Description

Steroids Use | Immunosuppressive Agents Use

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1524063
UMLS CUI [2,1]
C0021081
UMLS CUI [2,2]
C1524063
acei/arb treated patients should have 7-14 days wash out period，sidbp< 110mmhg
Description

Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Washout Period | Sitting diastolic blood pressure

Data type

boolean

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0521942
UMLS CUI [3]
C1710661
UMLS CUI [4]
C1319894
willing and able to comprehend and give written informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
willing to follow-up regularly
Description

Clinical Study Follow-up Regular Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C3274571
UMLS CUI [1,2]
C0205272
UMLS CUI [1,3]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
use steroids and immunosuppresive drugs
Description

Steroids Use | Immunosuppressive Agents Use

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1524063
UMLS CUI [2,1]
C0021081
UMLS CUI [2,2]
C1524063
secondary renal diseases
Description

Kidney Disease Secondary

Data type

boolean

Alias
UMLS CUI [1,1]
C0022658
UMLS CUI [1,2]
C0175668
acute cardio-cerebral diseases within 6 months
Description

Cardiovascular Diseases | Cerebrovascular Disorders

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0007820
post renal transplantation
Description

Kidney Transplantation Post

Data type

boolean

Alias
UMLS CUI [1,1]
C0022671
UMLS CUI [1,2]
C0687676
pregnant/nursing women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of hypersensitivity to acei/arb
Description

Hypersensitivity Angiotensin-Converting Enzyme Inhibitors | Hypersensitivity Angiotensin II receptor antagonist

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003015
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0521942
refuse to join clinical trial
Description

Study Subject Participation Status | Refusal to Participate

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C1136454
Back to the top of the page

Similar models

Eligibility Chronic Kidney Insufficiency NCT00565396

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients aged 18-75 years old
boolean
C0001779 (UMLS CUI [1])
Kidney Disease Secondary
Item
roll out secondary renal diseases
boolean
C0022658 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
Steroids Use | Immunosuppressive Agents Use
Item
do not use steroids and immunosuppresive drugs
boolean
C0038317 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0021081 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Washout Period | Sitting diastolic blood pressure
Item
acei/arb treated patients should have 7-14 days wash out period，sidbp< 110mmhg
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C1710661 (UMLS CUI [3])
C1319894 (UMLS CUI [4])
Informed consent
Item
willing and able to comprehend and give written informed consent
boolean
C0021430 (UMLS CUI [1])
Clinical Study Follow-up Regular Willing
Item
willing to follow-up regularly
boolean
C3274571 (UMLS CUI [1,1])
C0205272 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Steroids Use | Immunosuppressive Agents Use
Item
use steroids and immunosuppresive drugs
boolean
C0038317 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0021081 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
Kidney Disease Secondary
Item
secondary renal diseases
boolean
C0022658 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
Cardiovascular Diseases | Cerebrovascular Disorders
Item
acute cardio-cerebral diseases within 6 months
boolean
C0007222 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
Kidney Transplantation Post
Item
post renal transplantation
boolean
C0022671 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant/nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Hypersensitivity Angiotensin-Converting Enzyme Inhibitors | Hypersensitivity Angiotensin II receptor antagonist
Item
history of hypersensitivity to acei/arb
boolean
C0020517 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0521942 (UMLS CUI [2,2])
Study Subject Participation Status | Refusal to Participate
Item
refuse to join clinical trial
boolean
C2348568 (UMLS CUI [1])
C1136454 (UMLS CUI [2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial